Mitomycin C
| Product Name | Mitomycin C |
|---|---|
| Alternate Names | Mitomycin Impurities, Impurities of Mitomycin |
| CAT No. | CS-DE-00017 |
| CAS No. | 50-07-7 |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 334.33 g/mol |
| Mol. For. | C₁₅H₁₈N₄O₅ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Mitomycin |
| Purity | Not less than 95 % |
| Therapeutic | Anti-Cancer / Oncology, Anti Neo Plastic Agents |
| Smileys | CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Mitomycin C is an anti-cancer drug that is derived from Streptomyces caespitosus, a bacteria found in soil. It is commonly used in the treatment of various types of cancer, including stomach, pancreas, bladder, and breast cancer. Mitomycin C works by interfering with the DNA replication process of cancer cells, ultimately leading to the destruction of these cells.
Mitomycin C is administered intravenously by a healthcare professional. The dosage and frequency of administration will depend on the individual's medical history and the type of cancer being treated. Patients may experience side effects such as nausea, vomiting, hair loss, and fatigue during treatment. It is important for patients to discuss any concerns or side effects with their healthcare provider.
Chemically, Mitomycin C is a quinone-containing antibiotic that is structurally similar to other antibiotics such as doxorubicin and bleomycin. It works by binding to the DNA of cancer cells and inhibiting the synthesis of new DNA strands. This leads to the apoptosis, or programmed cell death, of cancer cells. Researchers continue to study Mitomycin C and its potential uses in cancer treatment, as well as its potential side effects and interactions with other medications.
Get an Instant Quote
Related Compounds
Decarbamoylmethylmitomycin A | Mitomycin RRT 1.44 | N-nitroso Mitomycin C | Mitomycin EP Impurity A | Mitomycin Related Compound 1 Hydrate | Mitomycin RRT 1.41 |